ℹ️ Observational Association Only Evidence
A longitudinal UK Biobank study followed 1,862 adults with remitted depression and 1,862 matched controls, tracking incident and relapse depression via hospital records and mental health questionnaires. Remitted depression conferred threefold higher odds of future depression; baseline cognitive performance showed divergent directional associations with risk depending on depression history.
Clinical Considerations
- Adults with remitted depression relapsed at more than twice the rate of controls developing first-episode depression (33% vs 13%) over follow-up
- In never-depressed controls, lower composite cognitive scores, particularly processing speed, reasoning, and executive function, were associated with higher future depression risk, consistent with cognitive decline as a vulnerability marker
- In remitted depression, the pattern reversed: higher cognitive performance was associated with greater relapse risk, with marginal depression probability increasing from 0.74% to 1.10% across the cognitive performance range
- Structural and functional MRI markers, including gray matter volume and network connectivity, were not associated with future depression risk despite group-level differences between remitted and control participants
Practice Applications
- Recognize that remitted depression remains a high-risk state regardless of current cognitive or functional status; relapse monitoring should be sustained, not contingent on apparent recovery
- Interpret higher cognitive functioning in remitted patients as compatible with, not protective against, future depressive episodes
- Avoid using cognitive performance alone as a surrogate for relapse risk stratification in this population
- Monitor processing speed deficits in never-depressed patients as a potential early vulnerability signal, pending replication in more diverse cohorts
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS